NCT05457673View on ClinicalTrials.gov

Subcostal Temporary Extravascular Pacing IV (STEP IV) Study

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 17, 2022

Primary Completion Date

September 22, 2022

Study Completion Date

October 20, 2022

Conditions
Conduction Defect
Interventions
DEVICE

AtaCor StealthTrac Lead

Subjects will receive the AtaCor StealthTrac Lead being evaluated in the study.

Trial Locations (1)

Unknown

Sanatorio Italiano, Asunción

Sponsors
All Listed Sponsors
lead

AtaCor Medical, Inc.

INDUSTRY

NCT05457673 - Subcostal Temporary Extravascular Pacing IV (STEP IV) Study | Biotech Hunter | Biotech Hunter